Interstitial KeratitisSymptoms, Doctors, Treatments, Advances & More
Learn About Interstitial Keratitis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
UPMC Vision Institute
Vishal Jhanji is an Ophthalmologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Jhanji is rated as an Elite provider by MediFind in the treatment of Interstitial Keratitis. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Interstitial Keratitis, Astigmatism, Keratoconus, Corneal Transplant, and Cataract Removal. Dr. Jhanji is currently accepting new patients.
Baylor College Of Medicine - Ophthalmology
Stephen Pflugfelder, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Stephen Pflugfelder specializes in Ophthalmology (Eye) and works at BCM Ophthalmology. To make an appointment, please call (713) 798-6100. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Pflugfelder is rated as an Elite provider by MediFind in the treatment of Interstitial Keratitis. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Interstitial Keratitis, Dry Eye Syndrome, Giant Papillary Conjunctivitis, Conjunctivitis (Pink Eye), and Corneal Transplant. Dr. Pflugfelder is currently accepting new patients.
Scheie Eye Institute Penn Presbyterian
Bennie Jeng is an Ophthalmologist practicing medicine in Philadelphia, Pennsylvania. Dr. Jeng is rated as an Elite provider by MediFind in the treatment of Interstitial Keratitis. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Interstitial Keratitis, Giant Papillary Conjunctivitis, Ligneous Conjunctivitis, Corneal Transplant, and Trabeculectomy. Dr. Jeng is board certified in Ophthalmology, 2004. Dr. Jeng is currently accepting new patients.
Summary: The aim of the study is to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants with Moderate to Severe Vernal Keratoconjunctivitis
Summary: This is a Phase II, double-blind, placebo-controlled study to evaluate the safety and efficacy of STSP-0902 ophthalmic solution in patients with neurotrophic keratitis (NK). The study plans to enroll 48 patients with Mackie Stage 2 or 3 NK affecting one or both eyes. Eligible subjects will be randomized 1:1:1 into three dosing groups. Each dosing group will follow a drug-placebo allocation (12 act...